Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry

HC So, CKL Chau, WT Chiu, KS Ho, CP Lo… - Nature …, 2017 - nature.com
Abstract Knowledge of psychiatric disease genetics has advanced rapidly during the past
decade with the advent of genome-wide association studies (GWAS). However, less progress …

Causal relationships between blood lipids and depression phenotypes: a Mendelian randomisation analysis

HC So, CK Chau, Y Cheng, PC Sham - Psychological Medicine, 2021 - cambridge.org
BackgroundThe etiology of depression remains poorly understood. Changes in blood lipid
levels were reported to be associated with depression and suicide, however study findings …

Differential associations of depression‐related phenotypes with cardiometabolic risks: Polygenic analyses and exploring shared genetic variants and pathways

BCF Wong, CKL Chau, FK Ao, CH Mo… - Depression and …, 2019 - Wiley Online Library
Background Numerous studies have suggested associations between depression and
cardiometabolic (CM) diseases. However, little is known about the mechanism underlying this …

Translating GWAS findings into therapies for depression and anxiety disorders: gene-set analyses reveal enrichment of psychiatric drug classes and implications for …

HC So, CKL Chau, A Lau, SY Wong… - Psychological Medicine, 2019 - cambridge.org
BackgroundDepression and anxiety disorders (AD) are the first and sixth leading causes of
disability worldwide. Despite their high prevalence and significant disability resulted, there …

Exploring causal relationships between COVID-19 and cardiometabolic disorders: a bi-directional Mendelian randomization study

Y Xiang, CKL Chau, J Qiu, S Rao, HC So - medRxiv, 2021 - medrxiv.org
Background More than 100 million cases of COVID-19 have been reported worldwide. A
number of risk factors for infection or severe infection have been identified, however …

Neuropsychiatric disorders as risk factors and consequences of COVID-19: a Mendelian randomization study

Y Xiang, J Qiu, R Zhang, CKL Chau, S Rao, HC So - medRxiv, 2021 - medrxiv.org
Background More than 180 million cases of COVID-19 have been reported worldwide. It has
been proposed that neuropsychiatric disorders may be risk factors and/or consequences of …

A framework to decipher the genetic architecture of combinations of complex diseases: applications in cardiovascular medicine

L Yin, CKL Chau, YP Lin, S Rao, Y Xiang… - …, 2021 - academic.oup.com
Motivation Currently, most genome-wide association studies (GWAS) are studies of a single
disease against controls. However, an individual is often affected by more than one condition…

Differential associations of various depression-related phenotypes with cardiometabolic risks: Identification of shared genetic factors and implications for drug …

BCF Wong, CKL Chau, FK Ao, CH Mo, SY Wong… - BioRxiv, 2017 - biorxiv.org
Numerous studies have suggested associations between depression and cardiometabolic
abnormalities or diseases, such as coronary artery disease and type 2 diabetes. However, …

Translating GWAS findings into therapies for depression and anxiety disorders: drug repositioning using gene-set analyses reveals enrichment of psychiatric drug …

HC So, A Lau, CKL Chau, SY Wong - bioRxiv, 2017 - biorxiv.org
Depression and anxiety disorders are the first and sixth leading cause of disability
worldwide according to latest reports from the World Health Organization. Despite their high …

Exploring repositioning opportunities and side-effects of statins: a Mendelian randomization study of HMG-CoA reductase inhibition with 55 complex traits

SO Hon-Cheong, CK Chau, K Zhao - bioRxiv, 2017 - biorxiv.org
Statin is one of the most commonly prescribed medications worldwide. Besides reduction of
cardiovascular risks, statins have been proposed for the prevention or treatment of other …